|
1
|
Long-term preservation of retinal function in the RCS rat model of retinitis pigmentosa following lentivirus-mediated gene therapy.
|
Gene Ther
|
2005
|
1.48
|
|
2
|
Intraocular gene delivery of ciliary neurotrophic factor results in significant loss of retinal function in normal mice and in the Prph2Rd2/Rd2 model of retinal degeneration.
|
Gene Ther
|
2003
|
1.17
|
|
3
|
EIAV vector-mediated delivery of endostatin or angiostatin inhibits angiogenesis and vascular hyperpermeability in experimental CNV.
|
Gene Ther
|
2006
|
1.07
|
|
4
|
RPE65 gene therapy slows cone loss in Rpe65-deficient dogs.
|
Gene Ther
|
2012
|
1.05
|
|
5
|
Stable and efficient intraocular gene transfer using pseudotyped EIAV lentiviral vectors.
|
J Gene Med
|
2006
|
0.99
|
|
6
|
AAV-mediated knockdown of peripherin-2 in vivo using miRNA-based hairpins.
|
Gene Ther
|
2009
|
0.98
|
|
7
|
Lentiviral-vector-mediated expression of murine IL-1 receptor antagonist or IL-10 reduces the severity of endotoxin-induced uveitis.
|
Gene Ther
|
2008
|
0.96
|
|
8
|
Gene supplementation therapy for recessive forms of inherited retinal dystrophies.
|
Gene Ther
|
2011
|
0.90
|
|
9
|
Kinetics of transgene expression in mouse retina following sub-retinal injection of recombinant adeno-associated virus.
|
Vision Res
|
2002
|
0.89
|
|
10
|
Absence of ocular malignant transformation after sub-retinal delivery of rAAV2/2 or integrating lentiviral vectors in p53-deficient mice.
|
Gene Ther
|
2011
|
0.76
|
|
11
|
Improvement of neuronal visual responses in the superior colliculus in Prph2(Rd2/Rd2) mice following gene therapy.
|
Mol Cell Neurosci
|
2004
|
0.76
|